Insights Widest with the analysis, Proactive gives perspectives that others don't.

Deep dive

Accesso Technology on track to meet full-year target after strong start to...

Following accesso’s announcement about putting itself up for sale, Peel Hunt repeated a ‘buy’...

4 days, 17 hours ago
Deep dive

Ashley House shifts focus towards modular buildings

The firm is involved in the design, construction, and management of health and social care...

4 days, 17 hours ago

Why does Ocado need more money – and does it matter?

How analysts treat the new convertible bond will be important, analyst Clive Black says, as on a...

6 days, 17 hours ago


Summit Therapeutics' Glyn Edwards talks US$50mln backing and ridinilazole...

Summit Therapeutics PLC's (LON:SUMM, NASDAQ:SMMT) CEO Glyn Edwards sat down with Proactive London's Andrew Scott following the news of a US$50mln funding deal with biotech billionaire Bob Duggan. The investment will help get the company’s next-generation antibiotic through phase III clinical...

8 hours, 28 minutes ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.